ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0843

Nephron Number Improves Prediction of Kidney Outcomes in IgAN

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • Yamaguchi, Yuya, Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
  • Sasaki, Takaya, Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
  • Tsuboi, Nobuo, Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
  • Marumoto, Hirokazu, Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
  • Okabayashi, Yusuke, Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
  • Haruhara, Kotaro, Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
  • Kanzaki, Go, Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
  • Koike, Kentaro, Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
  • D'Agati, Vivette D., Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, United States
  • Bertram, John F., Department of Anatomy and Developmental Biology, Biomedical Discovery Institute, Monash University, Melbourne, Victoria, Australia
  • Yokoo, Takashi, Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
Background

We estimated nephron number by combining kidney cortical volume estimated from non-contrast computed tomography with glomerular density obtained from kidney biopsy specimens among patients with IgA nephropathy. Whether the addition of nephron number improves predictability of a widely-validated International IgA Nephropathy Prediction Tool has not yet been investigated. We aimed to (i) validate the prediction tool in a Japanese cohort of patients with IgA nephropathy and (ii) assess the improvement of predictability by incorporating nephron number.

Methods

We analyzed patients with biopsy-proven IgA nephropathy whose nephron number was estimated by multiplying kidney cortical volume by non-sclerotic glomerular density. Predicted risk was assessed using the International Prediction Tool. The primary endpoint was a 50% decline in eGFR or kidney replacement therapy. Predictive performance was assessed using Harrell’s C-statistics, net reclassification improvement (NRI) and integrated discrimination improvement (IDI).

Results

We analyzed 218 patients (mean age 42.7 years, 61.7% male). Average nephron number was 680,000 (SD 390,000). During 5-year follow-up, 25 patients (11.5%) reached the composite endpoint. As shown in the Table, original prediction tool demonstrated good discrimination (C-statistics, 0.855). Incorporating nephron number into the model improved the predictive performance (C-statistics, 0.867; NRI, 0.544; IDI, 0.015).

Conclusion

The International IgA Nephropathy Prediction Tool demonstrated robust predictive performance in a Japanese cohort. Incorporation of the estimated nephron number enhanced risk discrimination, suggesting that nephron number may offer meaningful incremental prognostic value in the management of IgA nephropathy.

Risk prediction performance of the International Prediction Tool with nephron number
ModelHarrell’s C-statisticNRI (95% CI)IDI (95% CI)
International Prediction Tool0.855
+ Nephron Number0.8670.544 (0.144, 0.944)*0.015 (-0.025, 0.055)

*P = 0.011 CI, confidence interval; NRI, net reclassification improvement; IDI, integrated discrimination improvement.

Digital Object Identifier (DOI)